MERSANA THERAPEUTICS INC. - COMMON STOCK

Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

04 4 2024 16:30:28 提供 Nasdaq GlobeNewswire

Mersana Therapeutics Provides Business Update and Announces Fourth Quarter and Full Year 2023 Financial Results

28 2 2024 07:00:08 提供 Nasdaq GlobeNewswire

Mersana Therapeutics to Present at Upcoming Investor Conferences

27 2 2024 08:01:15 提供 Nasdaq GlobeNewswire

Mersana Therapeutics to Host Fourth Quarter and Year End 2023 Conference Call on February 28, 2024

21 2 2024 08:00:22 提供 Nasdaq GlobeNewswire

Mersana Therapeutics to Participate in Guggenheim’s 6th Annual Biotechnology Conference

01 2 2024 08:00:46 提供 Nasdaq GlobeNewswire

Mersana Therapeutics Announces Business Updates, Expected 2024 Milestones and Upcoming Presentation at the 42nd Annual J.P. Morgan Healthcare Conference

05 1 2024 08:01:19 提供 Nasdaq GlobeNewswire

Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01 12 2023 16:30:01 提供 Nasdaq GlobeNewswire

Mersana Therapeutics Provides Business Update and Announces Third Quarter 2023 Financial Results

07 11 2023 07:00:55 提供 Nasdaq GlobeNewswire

Mersana Therapeutics to Host Third Quarter 2023 Conference Call on November 7, 2023

31 10 2023 16:30:25 提供 Nasdaq GlobeNewswire

Mersana Therapeutics Announces FDA has Lifted Clinical Hold on Phase 1 Clinical Trial of XMT-2056

31 10 2023 08:00:01 提供 Nasdaq GlobeNewswire

Mersana Therapeutics Announces Changes in Leadership

06 9 2023 07:00:40 提供 Nasdaq GlobeNewswire

Mersana Therapeutics Announces Second Quarter 2023 Financial Results

08 8 2023 08:00:00 提供 Nasdaq GlobeNewswire

Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

04 8 2023 16:05:52 提供 Nasdaq GlobeNewswire

Mersana Therapeutics Announces Topline Data from UPLIFT Clinical Trial in Patients with Platinum-Resistant Ovarian Cancer and Strategic Reprioritization

27 7 2023 07:06:23 提供 Nasdaq GlobeNewswire

Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

06 7 2023 16:05:00 提供 Nasdaq GlobeNewswire

Mersana Therapeutics Announces Partial Clinical Hold on UP-NEXT and UPGRADE-A Clinical Trials

15 6 2023 07:30:00 提供 Nasdaq GlobeNewswire

Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

02 6 2023 16:05:00 提供 Nasdaq GlobeNewswire

Mersana Therapeutics to Present at Upcoming Investor Conferences

24 5 2023 08:00:01 提供 Nasdaq GlobeNewswire

Mersana Therapeutics Provides Business Update and Announces First Quarter 2023 Financial Results

09 5 2023 07:00:01 提供 Nasdaq GlobeNewswire

Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

04 5 2023 16:05:01 提供 Nasdaq GlobeNewswire